New Report Analyzes Impact of Limitations of Current Reimbursement System on Development of Novel Diagnostics

A report by Health Advances found that significant limitations in the current reimbursement system for novel diagnostics lead to inconsistent coverage decisions and impede the investment necessary for the development of the next generation of diagnostics. These limitations reduce patient access to novel diagnostics and, ultimately, to personalized medicine.